Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.155

Mar 13 2026 07:24 PM IST
share
Share Via
Sanjivani Paranteral Ltd’s shares declined to a fresh 52-week low of Rs.155 on 13 Mar 2026, marking a significant downturn amid broader market weakness. The stock has now recorded a three-day consecutive fall, shedding 6.75% over this period, underlining persistent pressures within the Pharmaceuticals & Biotechnology sector.
Sanjivani Paranteral Ltd Stock Falls to 52-Week Low of Rs.155

Recent Price Movement and Market Context

On the day in question, Sanjivani Paranteral Ltd touched an intraday low of Rs.155, representing a 6.65% drop from the previous close. This decline occurred despite the stock outperforming its sector by 0.42%, indicating relative resilience within a challenging environment. The broader market, however, was notably weak, with the Nifty index closing at 23,151.10, down 488.05 points or 2.06%. Several indices, including NIFTY MEDIA and NIFTY REALTY, also hit new 52-week lows, reflecting widespread selling pressure.

The stock’s current trading levels are below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a bearish technical setup. This technical weakness aligns with the stock’s underperformance over the past year, where it has declined by 36.82%, contrasting sharply with the Sensex’s modest 1.00% gain over the same period.

Performance Relative to Market and Sector

While the BSE500 index has generated a positive return of 5.44% in the last 12 months, Sanjivani Paranteral Ltd has lagged considerably, posting negative returns. This underperformance has contributed to the stock’s downgrade in Mojo Grade from Hold to Sell as of 23 Feb 2026, with a current Mojo Score of 47.0. The company is classified as a micro-cap within the Pharmaceuticals & Biotechnology sector, which has faced headwinds amid sectoral volatility and broader market corrections.

Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.

  • - Investment Committee approved
  • - 50+ candidates screened
  • - Strong post-announcement performance

See Why It Was Chosen →

Financial Metrics and Operational Highlights

Despite the share price decline, Sanjivani Paranteral Ltd exhibits several positive financial attributes. The company maintains a high return on equity (ROE) of 16.64%, indicating efficient utilisation of shareholder funds. Its debt servicing capability is strong, with a low Debt to EBITDA ratio of 0.86 times, suggesting manageable leverage levels.

Long-term growth prospects are reflected in the company’s operating profit, which has expanded at an annualised rate of 62.32%. The latest quarterly results for December 2025 reinforce this trend, with net sales reaching Rs.22.06 crores, a 28.0% increase compared to the previous four-quarter average. The PBDIT for the quarter was Rs.3.84 crores, the highest recorded, and the operating profit margin to net sales stood at 17.41%, also a peak figure.

Valuation and Profitability Considerations

Sanjivani Paranteral Ltd’s return on capital employed (ROCE) is 17.6%, which supports a fair valuation. The enterprise value to capital employed ratio is 3.9, indicating the stock is trading at a discount relative to its peers’ historical averages. However, the price-to-earnings-growth (PEG) ratio of 2.8 suggests that the market is pricing in slower profit growth relative to the company’s earnings expansion of 14.1% over the past year.

Shareholding and Market Capitalisation

The majority of Sanjivani Paranteral Ltd’s shares are held by non-institutional investors. The company is categorised as a micro-cap, which often entails higher volatility and sensitivity to market sentiment. This classification, combined with the recent price action, highlights the stock’s current risk profile within the Pharmaceuticals & Biotechnology sector.

Is Sanjivani Paranteral Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Technical Indicators and Market Sentiment

Technical analysis of Sanjivani Paranteral Ltd reveals predominantly bearish signals. The Moving Average Convergence Divergence (MACD) indicator is bearish on a weekly basis and mildly bearish monthly. Bollinger Bands also indicate bearish trends both weekly and monthly. The daily moving averages confirm a bearish stance, with the stock trading below all key averages.

Other technical measures such as the KST (Know Sure Thing) indicator and Dow Theory assessments are mildly bearish on monthly charts and bearish weekly. The Relative Strength Index (RSI) does not currently signal any strong momentum, while On-Balance Volume (OBV) data is inconclusive. Collectively, these indicators reflect subdued market sentiment towards the stock.

Sector and Market Environment

The Pharmaceuticals & Biotechnology sector has experienced volatility, with Sanjivani Paranteral Ltd’s performance mirroring broader sectoral pressures. The Nifty Midcap 100 index, a key benchmark for mid-sized companies, declined by 2.65%, dragging overall market sentiment lower. The Nifty index remains below its 50-day moving average, although the 50-day average is still above the 200-day average, suggesting a mixed medium-term outlook for the broader market.

Summary of Key Price Levels

The stock’s 52-week high was Rs.278, indicating a substantial decline of 44.2% from that peak to the current 52-week low of Rs.155. This wide trading range underscores the volatility experienced by Sanjivani Paranteral Ltd over the past year.

Conclusion

Sanjivani Paranteral Ltd’s fall to a new 52-week low at Rs.155 reflects a combination of market-wide weakness, sector-specific pressures, and technical bearishness. While the company demonstrates solid financial metrics such as strong ROE, manageable debt, and healthy profit growth, these factors have not translated into positive share price momentum over the past year. The downgrade in Mojo Grade to Sell further highlights the cautious stance adopted by market evaluators. Investors and analysts will continue to monitor the stock’s performance amid evolving market conditions and sector dynamics.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News